Personalized medicine

OTHER4 trials

Sponsors

M.D. Anderson Cancer Center, VUmc, Antoni van Leeuwenhoek Ziekenhuis, Vrije Universiteit Medisch Centrum

Conditions

Cancer tumorsRecurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphomablood poisoning infection infectious disease Sepsisblood poisoning infection sepsis Various infectious diseases

Early Phase 1

Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma

CompletedNCT03219047

M.D. Anderson Cancer CenterRecurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma

Start: 2018-12-20End: 2023-07-03Updated: 2023-07-27

Unknown Phase

Right Dose, Right Now: Model Validation

RecruitingNL-OMON45271

VUmcblood poisoning infection sepsis Various infectious diseases

Start: 2017-07-11Target: 500Updated: 2024-02-28

Right Dose, Right Now: Randomized Controlled Clinical Trial

Active, not recruitingNL-OMON53354

Vrije Universiteit Medisch Centrumblood poisoning infection infectious disease Sepsis

Start: 2018-02-19Target: 420Updated: 2024-02-28

WGS Implementation in standard cancer Diagnostics for Every cancer patient

Active, not recruitingNL-OMON49090

Antoni van Leeuwenhoek ZiekenhuisCancer tumors

Start: 2019-04-12Target: 1200Updated: 2024-02-28